Abstracts

A META GENOME-WIDE ASSOCIATION STUDY OF HIV-DISEASE PROGRESSION IN HIV CONTROLLERS

HIV-controllers are a heterogeneous group of individuals who maintain low or undetectable levels of viremia in the absence of antiretroviral treatment. Some of them eventually experience immunologic progression with marked CD4+ T-cell decline. Our aim was to identify genetic factors associated with avoiding CD4+ T-cell loss in HIV-controllers. Retrospective case-control genome wide association study (GWAS).…

THE VON HIPPEL–LINDAU CULLIN-RING E3 LIGASE REGULATES APOBEC3 CYTIDINE DEAMINASES

Human apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3 (APOBEC3; A3) cytidine deaminases can either promote cancer progression or defend against HIV. Nuclear-localized A3s, such as A3B, are at low or non-existent levels in primary cells, and often up-regulated in cancer cells causing pathogenic chromosomal mutagenesis. In contrast, increasing T lymphocyte content of cytoplasmic A3G decreases…

RESTRICTION OF HIV-1 INFECTION IN SICKLE CELL TRAIT

Patients with Sickle cell disease (SCD), an inherited hemoglobinopathy that affects approximately 100,000 people in the U.S, have lower risk for HIV-1 infection. We previously showed that ex vivo HIV-1 infection is restricted in SCD peripheral blood mononuclear cells (PBMCs), in part, due to the upregulation of antiviral, inflammatory and hemolytic factors including heme oxygenase-1…